INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $281,000 | -21.7% | 17,258 | -21.7% | 0.04% | -15.6% |
| Q4 2021 | $359,000 | -69.4% | 22,035 | -72.2% | 0.04% | -62.5% |
| Q3 2021 | $1,175,000 | +145.8% | 79,145 | +999.4% | 0.12% | +84.6% |
| Q3 2019 | $478,000 | -34.6% | 7,199 | -42.8% | 0.06% | +30.0% |
| Q3 2017 | $731,000 | +3.4% | 12,596 | +195.3% | 0.05% | +42.9% |
| Q3 2015 | $707,000 | +173.0% | 4,265 | +296.7% | 0.04% | +250.0% |
| Q2 2015 | $259,000 | -94.4% | 1,075 | -94.5% | 0.01% | -95.9% |
| Q3 2014 | $4,595,000 | +437.4% | 19,412 | +437.0% | 0.24% | +520.5% |
| Q2 2014 | $855,000 | -26.6% | 3,615 | +2.3% | 0.04% | -53.0% |
| Q1 2014 | $1,165,000 | – | 3,534 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |